Clinical Trials on Multiple Osteochondroma in Sweden

Total 258 results

Sahlgrenska University Hospital, Sweden

Completed

Prospective Follow up of Minimally Invasive Chest Wall Surgery After Trauma

Rib; Fracture, Multiple, With Flail Chest

Sweden
Karolinska Institutet
Patient-Centered Outcomes Research Institute; Kaiser Foundation Research Institute

Active, not recruiting

COMparison Between All immunoTherapies for Multiple Sclerosis. (COMBAT-MS)

Relapsing-remitting Multiple Sclerosis

Sweden
Anders Svenningsson
Västerbotten County Council, Sweden

Completed

Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis (ITT-PMS)

Progressive Multiple Sclerosis

Sweden
Karolinska Institutet

Completed

Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden

Multiple Sclerosis | Autologous Mesenchymal Stem Cells

Sweden
Bayer
Biogen Netherlands B.V; Novartis Europharm Limited; Merck Europe B.V.

Not yet recruiting

An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden (INFORM)

Multiple Sclerosis (MS)

Sweden, Finland
Karolinska Institutet

Completed

LDH as a Biochemical Biomarker to Predict Organ Failure in the Emergency Department Setting

Multiple Organ Failure

Sweden
Jan Lycke

Completed

Teriflunomide Concentration in Serum and Cerebrospinal Fluid From Patients With Multiple Sclerosis

Multiple Sclerosis, Pharmacokinetics

Sweden
BioInvent International AB

Terminated

A Phase II Study of BI-505 in Smoldering Multiple Myeloma

Smoldering Multiple Myeloma

Sweden
Bayer

Withdrawn

Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)

Multiple Sclerosis

Sweden, Denmark
Linkoeping University
CHU Dijon Bourgogne; Hospitaux Universitaires Paris Sud; Hôpital Dupuytren; CHU... and other collaborators

Recruiting

Sepsis in the ICU-II

Sepsis | Septic Shock | Cardiomyopathies | Organ Failure, Multiple

France, Sweden
Region Skane

Completed

Post-transfusion Platelet Count

Multiple Sclerosis | Leukemia

Sweden
Karolinska Institutet
The Swedish Research Council; Region Stockholm; Swedish Council for Working Life... and other collaborators

Completed

A Trial of a Client-centered Intervention Aiming to Improve Functioning in Daily Life After Stroke (LAS-2)

Stroke | Multiple Disability | Physical Disability

Sweden
Karolinska Institutet

Recruiting

Evaluation of a Self-management Program to Prevent Falls in People With Multiple Sclerosis (Fewer Falls)

Multiple Sclerosis

Sweden
Karolinska Institutet

Completed

Mesenchymal Stem Cells for Multiple Sclerosis

Multiple Sclerosis

Sweden
GeNeuro Innovation SAS

Terminated

A Long-term Extension of Study GNC-401

Multiple Sclerosis

Sweden
Haukeland University Hospital
Oslo University Hospital; University Hospital of North Norway; Helse Stavanger... and other collaborators

Active, not recruiting

Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease (OVERLORD-MS)

Relapsing Remitting Multiple Sclerosis

Norway, Sweden
Uppsala University
Karolinska University Hospital; Sahlgrenska University Hospital, Sweden; University... and other collaborators

Completed

Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden (AutoMS-Swe)

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting

Sweden
GeNeuro Innovation SAS

Completed

Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis (ProTEct-MS)

Multiple Sclerosis

Sweden
Karolinska Institutet
Karolinska University Hospital

Recruiting

Motor-cognitive Performance in People With Multiple Sclerosis (HiBalance-MS)

Multiple Sclerosis | Postural Balance

Sweden
Karolinska Institutet
The Swedish Research Council; Forte

Completed

A Self-management Program to Prevent Falls in People With Multiple Sclerosis

Multiple Sclerosis

Sweden
Biogen

Completed

Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS

Relapsing-remitting Multiple Sclerosis

Belgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
Karolinska Institutet
Neuro+

Completed

High-intensity Resistance Training in People With Multiple Sclerosis Experiencing Fatigue

Multiple Sclerosis | Fatigue | Cytokines | Resistance Training | Exercise Therapy

Sweden
Region Stockholm
Karolinska Institutet

Recruiting

High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill (HiPOXIC)

Hypoxia | Critical Illness | Respiratory Failure | Multi Organ Failure

Sweden
Karolinska Institutet
Sanofi; XNK Therapeutics AB, Sweden

Recruiting

Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma

Multiple Myeloma

Sweden
Karolinska University Hospital

Unknown

Clinical Study of Autologous Natural Killer Cells in Multiple Myeloma

Multiple Myeloma

Sweden
Uppsala University
Karolinska University Hospital; Sahlgrenska University Hospital, Sweden; University... and other collaborators

Completed

Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden (AutoCOVID-19)

Covid19 | Hematologic Neoplasms | Stem Cell Transplant Complications | Myeloma Multiple | Malignant Lymphoma

Sweden
GlaxoSmithKline

Terminated

Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM

Relapsed/Refractory Multiple Myeloma

Australia, Sweden, Canada
Hareth Nahi

Completed

Non-interventional Study on Time to Response and Quality of Life in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide in Second Line

Multiple Myeloma

Sweden
Nanexa AB
CTC Clinical Trial Consultants AB

Completed

To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects

Multiple Myeloma

Sweden
Karolinska University Hospital

Completed

Randomized Trial Comparing Lenalidomide With Low Dose Dexamethasone Versus Lenalidomide in Second Line Multiple Myeloma

Multiple Myeloma

Sweden
Örebro County Council
Norrbacka-Eugenia Foundation; Uppsala-Örebro Regional Research Council

Completed

Balance Training for People With Multiple Sclerosis Using Nintendo Wii Fit

Multiple Sclerosis

Sweden
Raija Silvennoinen
Bristol-Myers Squibb; Amgen; Hospital District of Helsinki and Uusimaa

Completed

Carfilzomib + Elotuzumab + Dexamethasone for Relapsed Multiple Myeloma After 1-3 Prior Treatment Lines (KEd)

Multiple Myeloma in Relapse

Finland, Sweden
Karolinska Institutet
Karolinska University Hospital

Recruiting

Walking and Thinking - Brain Activity During Complex Walking in People With Multiple Sclerosis

Multiple Sclerosis | Aging | Gait Disorders, Neurologic | Neuro-Degenerative Disease

Sweden
Merck KGaA, Darmstadt, Germany

Completed

A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif® With the RebiSmart™ Device (RebiQoL)

Multiple Sclerosis | Relapsing-Remitting

Sweden, Germany
Region Stockholm

Enrolling by invitation

Long Term Renal Function After CRRT in the Paediatric Intensive Care Unit, a Follow-up Study.

Acute Kidney Injury | Children, Only | Multi Organ Failure

Sweden
Bayer

Completed

Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers

Multiple Sclerosis | Positron-Emission Tomography

Australia, Sweden
Uppsala University

Recruiting

Mechanisms for Organ Dysfunction in Covid-19 (UMODCOVID19)

COVID-19 | Septic Shock | Acute Kidney Injury | Acute Respiratory Distress Syndrome | Organ Dysfunction Syndrome, Multiple | Organ Dysfunction Syndrome Sepsis

Sweden
Biogen

Completed

Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy (SAFE)

Multiple Sclerosis

Sweden
Anders Svenningsson

Completed

RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis. (RIFUND-MS)

Multiple Sclerosis, Relapsing-Remitting

Sweden
Otivio AS

Active, not recruiting

Performance and Long-term Safety of FlowOx2.0™ in Patients With Multiple Sclerosis - Impact on Spasticity and Pain (FO-NP002)

Multiple Sclerosis | Spasticity, Muscle | Pain, Chronic

Sweden
Danderyd Hospital

Completed

The Prognostic Significance of Premature Ventricular Complexes in Patients Without Structural Heart Disease (PULSE)

Premature Ventricular Contraction | Premature Ventricular Complexes Multiple

Sweden
Uppsala University

Unknown

Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita

Epidermolysis Bullosa Simplex

Sweden
Karolinska Institutet

Active, not recruiting

RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS (RIDOSE-MS)

Multiple Sclerosis, Relapsing-Remitting

Sweden
Uppsala University

Not yet recruiting

Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis

Multiple Sclerosis | Insomnia

Sweden
Biogen

Completed

Effects of Tysabri (BG00002) Over 12 Months on MS Related Fatigue in Participants With RRMS (TYNERGY)

Fatigue | Relapsing-Remitting Multiple Sclerosis

Sweden, Norway, Austria, Denmark
Eli Lilly and Company
BioMS Technology Corp.

Completed

A Study for Patients With Secondary Progressive Multiple Sclerosis (MAESTRO-01)

Secondary Progressive Multiple Sclerosis

Canada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
Sundsvall Hospital

Completed

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

Multiple Myeloma | Anemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma

Sweden
Örebro County Council
Norrbacka-Eugenia Foundation; Uppsala-Örebro Regional Research Council

Completed

Group Balance Training for People With Multiple Sclerosis

Multiple Sclerosis

Sweden
Eli Lilly and Company
BioMS Technology Corp.

Terminated

A Study for Patients With Multiple Sclerosis (MAESTRO-02)

Secondary Progressive Multiple Sclerosis

Canada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
Örebro County Council

Completed

Balance and Falls in Multiple Sclerosis

Multiple Sclerosis

Sweden

Clinical Trials on Multiple Osteochondroma in Sweden

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations